Insider Selling: Enliven Therapeutics (NASDAQ:ELVN) CEO Sells 1,000 Shares of Stock
MarketBeat
Enliven Therapeutics, Inc. (NASDAQ:ELVN - Get Free Report) CEO Samuel Kintz sold 1,000 shares of the business's stock in a transaction on Friday, September 19th. The shares were sold at an average price of $20.25, for a total transaction of $20,250.00. Following the completion of the transaction, the chief executive officer directly owned 921,892 shares in the company, valued at $18,668,313. This represents a 0.11% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
NASDAQ:ELVN